Giovanni Ciavarra (ISS Innovative Science Solutions, USA)
Neglecting key scientific developments can translate to missed opportunities and increased risks in the legal and business industries. The scientific and medical literature provides a significant source of information for stakeholders in these industries, but the ever-increasing pace and sophistication of emerging science can be daunting to track and review. In our years of experience working closely with regulated product manufacturers and their counsel, we continually encounter teams that struggle to keep up with new science in a systematic and organized fashion. However, when firms integrate systematic literature monitoring in their processes, these firms are up-to-date on the science and rather than playing catch-up, these teams are hard at work analyzing and developing new strategies based on the emerging science. This latter group is exemplary of the advantages offered to those firms and companies closely tracking key scientific developments. Technological developments are making literature monitoring and evaluation more effective and relevant to the intended audience. To enhance our work, we have recently initiated various collaborations to integrate new human-assisted big data and machine learning approaches to the identification and review of the literature. In this presentation, we will present our experiences working closely with attorneys handling complex scientific cases and how we support them in maintaining an awareness of the science, including some of the technologies we are integrating with our existing processes.